Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Moderate Hypofractionated(3Gy/f) Radiotherapy for Advanced Lung Cancer: a Retrospective Study.

NCT03833193 is registered in ClinicalTrials.gov with North China Petroleum Bureau General Hospital as lead sponsor.

NCT NCT03833193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03833193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Moderate Hypofractionated(3Gy/f) Radiotherapy for Advanced Lung Cancer: a Retrospective Study.
Lead sponsor
North China Petroleum Bureau General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2016
Completion date
March 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer